Regular paperPsychostimulant-like effects of p-fluoroamphetamine in the rat
References (50)
- et al.
Structure-activity relationships in CF3 substituted phenethylamines
- et al.
[3H]Cocaine binding and inhibition of [3H]dopamine uptake is similar in both the rat striatum and nucleus accumbens
Eur. J. Pharmacol.
(1989) - et al.
A drug discrimination analysis of the lysergic acid diethylamide (LSD): in vivo agonist and antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenpirone, a LSD-antagonist
J. Pharmacol. Exp. Ther.
(1982) - et al.
Comparison of the discriminative stimulus properties of cocaine and amphetamine in rats
Br. J. Pharmacol.
(1977) - et al.
6-Hydroxydopamine lesions of the nucleus accumbens attenuate the discriminative stimulus effects of d-amphetamine
Drug Dev. Res.
(1989) Structure-activity relationships among the halogenated amphetamines
Ann. NY Acad. Sci.
(1978)- et al.
Influence of ring and side substituents on the selectivity of amphetamine as a monoamine oxidase inhibitor
Res. Commun. Subst. Abuse
(1982) - et al.
Lowering of brain serotonin level by chloroamphetamines
Biochemical Pharmacol.
(1965) - et al.
Comparison of 4-chloro-, 4-bromo- and 4-fluoroamphetamine in rats: drug levels in brain and effects on brain serotoninserotonim metabolism
Neuropharmacology
(1975) - et al.
Effect of 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine on the depletion of brain serotonin by 4-chloroamphetamine
J. Pharmacol. Exp. Ther.
(1975)
Reversible and irreversible phases of serotonin depletion by 4-chloroamphetamine
Eur. J. Pharmacol.
Role of dopamine D1 and D2 receptors in mediating the d-amphetamine discriminative cue
Eur. J. Pharmacol.
Biochemical pharmacology of the anorectic drug fenfluramine: a review
Curr. Med. Res. Opin.
Structure-activity studies on amphetamine analogs using drug discrimination methodology
Pharmacol. Biochem. Behav.
Regional studies of catecholamines in the rat brain. I. The disposition of [3H]-norepinephrine, [3H]-dopamine and [3H]DOPA in various regions of the brain
J. Neurochem.
A comparison of fenfluramine and amphetamine in man
Clin. Pharmacol. Ther.
p-Chloroamphetamine: Selective neurotoxic actions in brain
Science
Comparison between the neurotoxic and serotonin depleting effects of various halogenated derivatives of amphetamine in the rat
J. Pharmacol. Exp. Ther.
Role of dopamine of d-amphetamine-induced discriminative responding
Pharmacol. Biochem. Behav.
Stimulants as discriminative stimuli
[3H]Monoamine releasing and uptake inhibition properties of 3,4-methylenedioxymethamphetamine and p-chioroamphetamine analogues
Eur. J. Pharmacol.
Synthesis and pharmacological examination ofexaminationof 1-(3-methoxy-4-methylphenyl)-2-aminopropane and 5-methoxy-6-methyl-2-aminoindan: similarities to 3,4-methylenedioxymeth-amphetamine (MDMA)
J. Med. Chem.
Drug discrimination by humans compared to nonhumans: current status and future directions
Psychopharmacology
Biochemical actions of amphetamine and other stimulants
A simplified method of evaluating dose-effect experiments
J. Pharmacol. Exp. Ther.
Cited by (43)
Synthetic amphetamine derivatives, benzofurans, and benzodifurans
2021, Novel Psychoactive Substances: Classification, Pharmacology and ToxicologyNovel halogenated synthetic cannabinoids impair sensorimotor functions in mice
2020, NeuroToxicologyIdentification and characterization of 4-chloromethamphetamine (4-CMA) in seized ecstacy — a risk to public health
2018, Forensic Science InternationalCitation Excerpt :Based on these in vivo rat data one might expect 4-CA to have about four times the potency of MDMA. Also, in a study performed in 1995 it was demonstrated that 4-CA is a more potent 5-HT uptake inhibitor than amphetamine or 4-fluoroamphetamine, although less potent at dopamine and norepinephrine reuptake sites [17]. 4-CMA is the N-methylated derivative of 4-CA and will be more lipophilic and hence more likely to penetrate the blood–brain barrier and potentially more potent in vivo than 4-CA itself.
Effect fingerprinting of new psychoactive substances (NPS): What can we learn from in vitro data?
2018, Pharmacology and TherapeuticsRole of dopamine D1 receptor in 3-fluoromethamphetamine-induced neurotoxicity in mice
2018, Neurochemistry InternationalCitation Excerpt :3-FMA has been associated with increased risk of death in Finland, England and Wales (Vili et al., 2012; Statistics, 2015; Shapiro, 2016) and listed as a restricted drug in West Virginia, U.S.A (Laws, 2015). An earlier study has shown that fluorinated derivatives of AMPH exhibited psychostimulant-like properties (Marona-Lewicka et al., 1995). In addition, the behavioral and neurotoxic effects induced by 3-FMA currently remain unknown.
- a
Present address: Department of Pharmaceutical and Biomedical Sciences, Raabe College of Pharmacy, Ohio Northern University, Ada, OH 45810, USA.